Product Information

DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7152 per EA under NDC 72205020260. Its NADAC has been published 115 times since Sep 4, 2024.

FDA first approved this application on May 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DABIGATRAN ETEXILATE 75 MG CAP

DABIGATRAN ETEXILATE
$0.7152per EA

Strength

75 mg/1

NDC

72205020260

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213879

FDA Approved

5/22/2024

TE Code

AB

On Market Since

5/22/2024

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price Statistics

The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 115 times since Sep 4, 2024, and over the history we have for it it has declined 65.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7152 per EA
All-time high$2.1906 (Dec 11, 2024)
All-time low$0.7152 (Oct 21, 2026)
52-week high$1.1059
52-week low$0.7152
Median price$1.1261
Average price$1.3416
Largest weekly change-11.0% (Aug 20, 2025)
Weeks tracked115
Tracking sinceSep 4, 2024

Price History

1W

0.0%

1M

-4.7%

3M

-20.4%

6M

-15.6%

1Y

-36.5%

3Y

N/A

5Y

N/A

All

-65.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Novadoz Pharmaceuticals LLC, is $0.7152 per EA (NDC 72205020260), effective Nov 11, 2026.

How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?

Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 65.6%. It has been tracked across 115 weekly CMS publications since Sep 4, 2024.

What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?

Since Sep 4, 2024, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.7152 (Oct 21, 2026) to a high of $2.1906 (Dec 11, 2024), with a median of $1.1261 per EA.

Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 75 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?

DABIGATRAN ETEXILATE 75 MG CAP (NDC 72205020260) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.